We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.68B
AUM Growth
-$209M
Cap. Flow
-$341M
Cap. Flow %
-9.26%
Top 10 Hldgs %
13.58%
Holding
1,437
New
112
Increased
524
Reduced
590
Closed
111

Sector Composition

Rank Sector Weight
1 Technology 12.63%
2 Healthcare 11.47%
3 Financials 11.29%
4 Industrials 9.35%
5 Consumer Discretionary 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACBI
1226
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$197K 0.01%
10,000
ATXS
1227
DELISTED
Astria Therapeutics
ATXS
$190K 0.01%
3,300
+400
+14% +$36.9K
CHI
1228
Calamos Convertible Opportunities and Income Fund
CHI
$999M
$188K 0.01%
15,962
MERC icon
1229
Mercer International
MERC
$39.5M
$188K 0.01%
+10,770
New +$162K
AFB
1230
AllianceBernstein National Municipal Income Fund
AFB
$314M
$186K 0.01%
14,750
+1,500
+11% +$18.8K
FAX
1231
abrdn Asia-Pacific Income Fund
FAX
$597M
$186K 0.01%
7,171
-1,608
-18% -$43.7K
GEG icon
1232
Great Elm Group
GEG
$68.4M
$186K 0.01%
51,644
-1,649
-3% -$6.25K
PUMP icon
1233
ProPetro Holding
PUMP
$1.33B
$180K ﹤0.01%
+11,495
New +$198K
PMO
1234
Franklin Municipal Opportunities Trust
PMO
$280M
$179K ﹤0.01%
+15,350
New +$179K
ICMB icon
1235
Investcorp Credit Management BDC
ICMB
$11.2M
$176K ﹤0.01%
19,897
-3,901
-16% -$33.7K
VOXX
1236
DELISTED
VOXX International Corporation Class A
VOXX
$176K ﹤0.01%
32,500
+500
+2% +$2.64K
MBI icon
1237
MBIA
MBI
$274M
$174K ﹤0.01%
19,300
-8,400
-30% -$75.8K
GARS
1238
DELISTED
Garrison Capital Inc.
GARS
$173K ﹤0.01%
21,224
-11,949
-36% -$100K
CIG icon
1239
CEMIG Preferred Shares
CIG
$6.21B
$172K ﹤0.01%
183,515
-196
-0.1% -$212
BCS icon
1240
Barclays
BCS
$93.4B
$171K ﹤0.01%
17,905
+1,046
+6% +$11.3K
FIV
1241
DELISTED
First Trust Senior Floating Rate 2022 Target Term Fund Common Shares of Beneficial Interest
FIV
$171K ﹤0.01%
18,500
-10,000
-35% -$93.9K
HLX icon
1242
Helix Energy Solutions
HLX
$1.36B
$167K ﹤0.01%
+20,000
New +$147K
PRTA icon
1243
Prothena Corp
PRTA
$440M
$166K ﹤0.01%
11,455
+3,700
+48% +$73.1K
CEM
1244
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
$165K ﹤0.01%
2,334
-496
-18% -$34.9K
VVR icon
1245
Invesco Senior Income Trust
VVR
$459M
$163K ﹤0.01%
38,146
-9,779
-20% -$43K
ERC
1246
Allspring Multi-Sector Income Fund
ERC
$254M
$162K ﹤0.01%
13,000
RDC
1247
DELISTED
Rowan Companies Plc
RDC
$162K ﹤0.01%
+10,000
New +$150K
ACCO icon
1248
Acco Brands
ACCO
$390M
$158K ﹤0.01%
11,442
-5
-0% -$64
STGW icon
1249
Stagwell
STGW
$2.1B
$158K ﹤0.01%
34,240
+10,050
+42% +$58.6K
KND
1250
DELISTED
Kindred Healthcare
KND
$158K ﹤0.01%
17,500

Similar funds

Oppenheimer & Co's Q2 2018 Portfolio in Review

As of Q2 2018, Oppenheimer & Co held 1,437 positions worth $3.68B, down 5.4% from $3.89B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co withdrew a net $341M in Q2 2018, closing 111 positions and reducing 590 holdings. Its most notable exit was Monsanto Co, an estimated $9.28M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oppenheimer & Co opened a new position in Thor Industries worth $3.01M.

  • Oppenheimer & Co's largest Q2 2018 buy was Thor Industries: 30,900 shares worth $3.01M.
  • Oppenheimer & Co added most to AT&T in Q2 2018, an estimated $7.02M increase.
  • Oppenheimer & Co's biggest Q2 2018 reduction was Foundation Medicine, Inc., cutting an estimated $63.6M.
  • Oppenheimer & Co fully exited Monsanto Co in Q2 2018, selling an estimated $9.28M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.68B portfolio in Q2 2018.
  • Oppenheimer & Co opened 112 new positions and closed 111 in Q2 2018.
  • Oppenheimer & Co's portfolio value fell 5.4% quarter-over-quarter to $3.68B.

Based on Oppenheimer & Co's 13F filing for Q2 2018, filed 10 Aug 2018.